Macrophage genetic reprogramming during chronic peritonitis is augmented by LPS pretreatment

Area of Science:

• Immunology
• Microbiology
• Molecular Biology

Background:

• Chronic peritonitis poses challenges in critically ill patients, potentially due to microbial tolerance, a state of diminished inflammatory response.
• Microbial tolerance involves a reduced pro-inflammatory protein response after repeated exposure to pathogen-associated molecular patterns (PAMPs).
• This study explores the molecular mechanisms underlying microbial tolerance and early innate immune response resolution in a novel chronic peritonitis model.

Purpose of the Study:

• To investigate the molecular mechanisms behind microbial tolerance in chronic peritonitis.
• To analyze the early innate immune response resolution following infection.
• To determine the effect of lipopolysaccharide (LPS) pretreatment on the immune response to Klebsiella pneumonia.

Main Methods:

• C57BL/6 mice were pretreated with saline or LPS (10 mg/kg) intraperitoneally.
• Peritonitis was induced 24 hours later with Klebsiella pneumonia (10^3 CFU IP), and gentamicin was administered.
• Peritoneal exudate cells (PECs) were collected at 4, 24, and 48 hours post-infection for gene expression analysis using RT2-Profiler PCR arrays and Ingenuity Pathway Analysis (IPA).

Main Results:

• Peritonitis increased PEC gene expression related to sepsis and inflammation.
• LPS pretreatment augmented gene expression in the initial 24 hours post-infection compared to saline pretreatment.
• Six canonical pathways, including Toll-like receptor and NF-κB signaling, were consistently dysregulated in both groups.

Conclusions:

• Prior LPS exposure did not induce microbial tolerance at the mRNA level in peritoneal cells against Klebsiella infection.
• The augmented inflammatory response due to LPS pretreatment was transient, lasting up to 24 hours.
• Post-transcriptional modifications, such as microRNA down-regulation, may explain the observed lack of tolerance.